- Home
- ACHV vs CURR Comparison
ACHV vs CURR Comparison
Compare ACHV & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- CURR
- Stock Information
- Founded
- ACHV N/A
- CURR 2013
- Country
- ACHV United States
- CURR Singapore
- Employees
- ACHV N/A
- CURR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CURR Business Services
- Sector
- ACHV Health Care
- CURR Consumer Discretionary
- Exchange
- ACHV Nasdaq
- CURR Nasdaq
- Market Cap
- ACHV 153.8M
- CURR 151.4M
- IPO Year
- ACHV N/A
- CURR N/A
- Fundamental
- Price
- ACHV $3.15
- CURR $1.57
- Analyst Decision
- ACHV Strong Buy
- CURR Strong Buy
- Analyst Count
- ACHV 2
- CURR 1
- Target Price
- ACHV $16.00
- CURR $3.50
- AVG Volume (30 Days)
- ACHV 867.2K
- CURR 153.3K
- Earning Date
- ACHV 11-06-2025
- CURR 11-18-2025
- Dividend Yield
- ACHV N/A
- CURR N/A
- EPS Growth
- ACHV N/A
- CURR N/A
- EPS
- ACHV N/A
- CURR N/A
- Revenue
- ACHV N/A
- CURR $41,092,419.00
- Revenue This Year
- ACHV N/A
- CURR N/A
- Revenue Next Year
- ACHV N/A
- CURR $14.56
- P/E Ratio
- ACHV N/A
- CURR N/A
- Revenue Growth
- ACHV N/A
- CURR N/A
- 52 Week Low
- ACHV $1.84
- CURR $0.33
- 52 Week High
- ACHV $5.31
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- ACHV 56.75
- CURR 43.60
- Support Level
- ACHV $3.07
- CURR $1.56
- Resistance Level
- ACHV $3.21
- CURR $1.79
- Average True Range (ATR)
- ACHV 0.14
- CURR 0.10
- MACD
- ACHV 0.01
- CURR -0.00
- Stochastic Oscillator
- ACHV 77.55
- CURR 15.44
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.